Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released Aug 6, 2013, after the close
10-Q filed Aug 6, 2013, 37 days after period end · 0001193125-13-321550
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2013 | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|---|
| Revenue | $451.00K | $599.00K | $460.00K | $2.30M |
| Net Income | -$9.08M | -$5.42M | -$6.56M | -$4.29M |
| EPS Diluted | -$0.11 |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.10 |
| -$0.12 |
| -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
